Analyzing Multiple Endpoints

نویسنده

  • Claudine Legault
چکیده

CLAUDINE LEGAULT. Analyzing Multiple Endpoints with a two-stage group sequential design in clinical trials. (Under the direction of Timothy M. Morgan.) In many clinical trials, the assessment of the response to the various treatments can include a large variety of outcome variables which are generally correlated. Different endpoints may be regarded by the investigators as important in determining if a certain treatment is effective. The more variables there are, the more likely it is that differences will appear at random if adjustments are not made for the multiple tests. Bonferroni's adjustment for multiple comparisons is one of the approaches used when multiple correlated outcomes are being compared. For alternative hypotheses in which several endpoints are affected in the same direction, Bonferroni's procedure may lack power because the rejection of the overall hypothesis is based on the smallest pvalue of all the test. statistics. Hotelling's T 2 makes no distinction between variables that change favorably and variables that change unfavorably. It lacks power to detect any specific types of departure considered a priori to be biologically plausible in a clinical trial and was therefore considered unsuitable by Pocock (1987) for the analysis of clinical trials. A test proposed by O'Brien (1984) focusses on alternative hypotheses with all endpoints showing an effect in the same direction. In that situation it provides better power but it deteriorates sharply to a power of only 5% when variables are affected in opposite directions. This dissertation first compares the critical regions and the power contours of the three procedures mentioned above. The efficiency and robustness of these procedures are compared as a function of the direction of the alternative hypotheses. A new test is first derived using data from the interim look in a two-stage group sequential design to form the rejection boundary at the second stage. Initially, the test uses an Hotelling T 2 rejection region at the end of the first stage and an O'Brien 'type' procedure at the end of the second stage. The test is then extended to allow for early acceptance. The distribution of the proposed tests is presented and their power and efficiency are compared to common procedures. Finally, two examples are presented and future research recommendations are discussed.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Analysis of Multiple Endpoints in Clinical Trials

Most human diseases are characterized by multidimensional etiology and the efficacy of an experimental treatment frequently needs to be assessed on multiple outcome measures — commonly referred to as endpoints. There is a variety of ways in which the contribution of each endpoint can be accounted for in the primary analysis, for example, the trial’s sponsor can treat endpoints as independent en...

متن کامل

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.

The increasing complexity of randomized clinical trials and the practice of obtaining a wide variety of measurements from study participants have made the consideration of multiple endpoints a critically important issue in the design, analysis, and interpretation of clinical trials. Failure to consider important outcomes can limit the validity and utility of clinical trials; specifying multiple...

متن کامل

Statistical grand rounds: design and analysis of studies with binary- event composite endpoints: guidelines for anesthesia research.

Composite endpoints consisting of several binary events, such as distinct perioperative complications, are frequently chosen as the primary outcome in anesthesia studies (and in many other clinical specialties) because (1) no single outcome fully characterizes the disease or outcome of interest, and/or (2) individual outcomes are rare and statistical power would be inadequate for any single one...

متن کامل

Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review

BACKGROUND So far, clinical studies in primary progressive MS (PPMS) have failed to meet their primary efficacy endpoints. To some extent this might be attributable to the choice of assessments or to the selection of the study population. OBJECTIVE The aim of this study was to identify outcome influencing factors by analyzing the design and methods of previous randomized studies in PPMS patie...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 1991